天茂实业集团股份有限公司 股东会议事规则 第一章 总则 第一条 为规范天茂实业集团股份有限公司（以下简称"公司"）行为，保证股东会 依法行使职权，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）等法律、法规和《天茂实业 集团股份有限公司章程》（以下简称"《公司章程》"）的规定，制定本规则。 第二条 公司股东会的召集、提案、通知、召开等事项适用本规则。 公司应当严格按照法律、行政法规、《公司章程》及本议事规则的相关规定召开股东 会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当勤勉尽责， 确保股东会正常召开和依法行使职权。 第三条 股东会应当在《公司法》和公司章程规定的范围内行使职权。 第四条 股东会分为年度股东会和临时股东会。年度股东会每年召开一次，应当于上 一会计年度结束后的六个月内举行。临时股东会不定期召开，出现《公司法》第一百一十 三条规定的应当召开临时股东会的情形时，临时股东会应当在两个月内召开。 第五条 公司召开股东会，应当聘请律师对以下问题出具法律意见并公告： （一）会议的召集、召开程序是否 ...

Core Viewpoint - The A-share market is experiencing an accelerated pace of delisting, with a significant increase in companies being warned or forced to delist due to various regulatory standards and stricter enforcement of delisting policies [1][2][3][4]. Group 1: Delisting Risks and Statistics - *ST Tianmao issued its fourth risk warning regarding potential delisting due to failure to disclose its 2024 annual report and 2025 quarterly report within the stipulated timeframe [1]. - As of August 7, 2023, 23 A-share companies have been delisted this year, with 8 due to trading-related delisting (e.g., stock price below par), 7 for compliance issues, and 3 for voluntary delisting [1][2]. - The number of delisted companies has significantly increased since 2019, with 212 companies delisted from 2019 to the present, surpassing the total from the previous 20 years [2]. Group 2: Regulatory Changes and Impact - The introduction of the "New National Nine Articles" in April 2022 has led to stricter enforcement of delisting standards, particularly for companies involved in serious violations [3][4]. - The revised stock listing rules have raised the revenue threshold for financial delisting from 1 billion to 3 billion yuan, indicating a tightening of financial health requirements for listed companies [4]. - As of now, 107 companies are under delisting risk warnings due to financial issues, and 118 companies face compliance-related delisting risks [4][5]. Group 3: Market Dynamics and Future Outlook - The trend towards a normalized delisting mechanism is expected to continue, with a focus on improving investor protection and eliminating the expectation of "shell value" [1][4]. - The new regulations are anticipated to accelerate the exit of loss-making companies from the capital market, thereby promoting structural reforms in the supply side of the economy [5].

Core Viewpoint - *ST Tianmao is likely planning to voluntarily delist due to ongoing financial difficulties and regulatory pressures, following a series of failures to disclose financial reports on time [1][4]. Group 1: Company Background - *ST Tianmao, originally named Baike Pharmaceutical, was established in 1993 and is controlled by Liu Yiqian through New Liyi Group [3]. - The company primarily engages in life insurance and insurance intermediary services through its subsidiaries, Guohua Life and Huarui Insurance [3]. - As of the end of Q3 2024, *ST Tianmao's total assets were approximately 285.2 billion yuan, with Liu Yiqian and his spouse holding a combined 66.28% of the shares [3]. Group 2: Financial Performance - The company projected a revenue of 40 billion to 43 billion yuan for 2024, with expected losses ranging from 500 million to 750 million yuan [3]. - The losses are attributed to a declining interest rate environment, which has led to increased reserve provisions for Guohua Life, resulting in consecutive years of losses [3]. Group 3: Regulatory Issues - The company has faced regulatory scrutiny, including an investigation by the China Securities Regulatory Commission for failing to disclose financial reports on time [2][4]. - Following the failure to disclose the 2024 annual report and the 2025 Q1 report, *ST Tianmao's stock was subject to a delisting risk warning [2][4]. Group 4: Market Reaction and Strategic Considerations - Since the implementation of the delisting risk warning, *ST Tianmao's stock price has dropped over 47%, closing at 1.45 yuan per share, with a total market capitalization of 7.111 billion yuan as of August 6 [4]. - The potential voluntary delisting may be a strategic move to mitigate further losses and legal liabilities, as the company faces increasing operational challenges and regulatory pressures [4].

Group 1 - Tianeng Heavy Industry plans to reduce its shareholding by up to 2.94%, totaling no more than 30.08 million shares [1] - Huafa Co. has received approval from the China Securities Regulatory Commission to issue convertible bonds to specific investors [1] - ST Jiaotou has been identified as the first candidate for the general contracting of a project with a total investment of 58.28 million yuan [1] Group 2 - Pizaihuang's subsidiary plans to invest 200 million yuan in a health industry investment fund with a target size of 1 billion yuan [2] - ST Weihai has been selected as a candidate for a design and construction project with a bid of 156 million yuan [4] - Kangqiang Electronics plans to reduce its shareholding by up to 1%, totaling no more than 3.75 million shares [6] Group 3 - Zongsheng Pharmaceutical's vice president plans to reduce his shareholding by up to 900,000 shares [6] - Tapai Group reported a net profit of 435 million yuan for the first half of the year, a year-on-year increase of 92.47% [7] - Tapai Group plans to repurchase shares worth between 50 million and 100 million yuan [7] Group 4 - Xinghua Co.'s subsidiary has completed annual maintenance and resumed production [8] - Huaxi Co. intends to acquire 100% equity of Xiefeng Cotton and Hemp for 90 million yuan [9] - Mind Electronics' major shareholders plan to reduce their holdings by a total of 4% [10] Group 5 - Tianhe Co.'s director plans to reduce his shareholding by up to 0.15% [11] - Longxin Zhongke's shareholders plan to transfer a total of 1.37% of the company's shares through a private transfer [12] - Kory Technology's major shareholders plan to reduce their holdings by up to 3.03% [13] Group 6 - Hehua Co. is undergoing a change in actual control, with stock resuming trading [14] - Focus Media plans to acquire 100% of New潮传媒 for 8.3 billion yuan [15] - Lionhead Co. intends to acquire 97.44% of Lipu Technology for 662 million yuan [16] Group 7 - ST Tianmao's major shareholder is planning a significant matter, leading to a temporary suspension of stock trading [18] - Lianjian Technology plans to acquire 60% of Zhongren Tongce for 21 million yuan [19]

中国经济网北京8月7日讯*ST天茂（000627）(000627.SZ)昨晚发布关于筹划重大事项停牌的公告。天茂 实业集团股份有限公司(以下简称"公司")于2025年8月6日收到公司控股股东新理益集团有限公司(以下简 称"新理益")《关于筹划重大事项申请股票停牌的函》，新理益正在筹划与公司相关的重大事项。 鉴于上述事项尚存在重大不确定性，为维护中小股东利益，避免造成公司股价异常波动，根据《深圳证 券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第6号——停复牌》等有关规定，经 公司向深圳证券交易所申请，公司股票(股票简称：*ST天茂，股票代码：000627)自2025年8月7日(星期 四)开市起停牌，预计停牌时间不超过2个交易日。 ...

Market Overview - On August 6, the A-share market experienced a slight upward trend with the Shanghai Composite Index rising by 0.45% to 3633.99 points, the Shenzhen Component Index increasing by 0.64% to 11177.78 points, and the ChiNext Index gaining 0.66% to 2358.95 points. The total trading volume reached 1.73 trillion yuan, an increase of 138 billion yuan compared to the previous trading day [2] - The U.S. stock market also saw gains on August 6, with the Dow Jones Industrial Average up by 0.18% to 44193.12 points, the S&P 500 rising by 0.73% to 6345.06 points, and the Nasdaq Composite increasing by 1.21% to 21169.42 points [2][5] - European stock indices all closed higher on August 6, with the FTSE 100 up by 0.24%, the CAC 40 up by 0.18%, and the DAX up by 0.33% [3][4] Sector Performance - In the A-share market, sectors such as PEEK materials, humanoid robots, and photolithography machines showed significant gains, while traditional Chinese medicine, tourism, and innovative pharmaceuticals faced declines [2] - The main sectors with net inflows included general equipment, automotive parts, and specialized equipment, while the chemical pharmaceuticals sector experienced the largest net outflow [12] Company News - Li Auto, China Automotive Technology and Research Center, and Dongfeng Liuzhou Motor reached a consensus regarding the Li Auto i8 collision test incident, emphasizing the importance of maintaining integrity and avoiding unfair competition in the automotive industry [6] - Biogen announced an expected revenue range of 35.8 billion to 38.1 billion yuan for 2025 [11] - SINO Medical's subsidiary received breakthrough medical device designation from the FDA for a product treating intracranial atherosclerosis, marking a significant milestone [11] Policy and Development Initiatives - The State Grid reported a record high electricity load of 1.233 billion kilowatts from August 4 to 6, reflecting a significant increase from last year's peak [7] - The Shanghai government released a plan to develop the embodied intelligence industry, aiming for a core industry scale of over 50 billion yuan by 2027 [8]

Group 1: Company News - *ST Tianmao announced that its controlling shareholder is planning significant matters related to the company, leading to a stock suspension starting August 7, expected to last no more than 2 trading days [6] - *ST Yazhen's stock will be suspended from trading starting August 7 due to abnormal price fluctuations, with a cumulative increase of 33.92% from July 30 to August 6 [6][7] - Xianhe Co. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project in Sichuan, with an expected annual output value of about 5.15 billion yuan after the first phase [6] - Hehua Co. announced a change in its actual controller due to the transfer of 100% equity of its controlling shareholder, with a total transaction price of 692 million yuan [8] - Fenzhong Media intends to acquire 100% equity of New潮传媒 for 8.3 billion yuan, which will become a wholly-owned subsidiary [8] Group 2: Industry News - The People's Bank of China has 283.2 billion yuan of 7-day reverse repos maturing today, indicating ongoing liquidity management in the financial market [2] - The National Development and Reform Commission and the National Energy Administration have issued basic rules for electricity market measurement and settlement, effective from October 1, marking a significant step towards a unified national electricity market [2] - The China Photovoltaic Industry Association is soliciting opinions on the draft amendment to the Price Law, focusing on price behavior norms and regulatory mechanisms [3]

Core Viewpoint - *ST Tianmao is facing a potential delisting crisis but has announced a significant matter being planned by its controlling shareholder, Xinliyi Group, which may provide a new opportunity for the company [1][3]. Group 1: Company Situation - *ST Tianmao has received a notice from Xinliyi regarding the planning of a significant matter, leading to a temporary suspension of its stock trading starting August 7, with an expected duration of no more than two trading days [3]. - The company is currently in a delisting crisis due to its failure to disclose the 2024 annual report and the 2025 first-quarter report within the legal deadlines, resulting in a delisting risk warning implemented on July 8 [3]. - As of August 6, *ST Tianmao has not yet disclosed its financial reports, but it claims that normal operations are ongoing and that it is working to complete the necessary reports [3]. Group 2: Financial Performance - *ST Tianmao, as an investment holding company, primarily engages in insurance business through its subsidiaries, Guohua Life and Huarui Insurance, with Guohua Life being a nationwide life insurance company [4]. - As of June 30 of the previous year, Guohua Life had total assets of 271.599 billion and net assets of 26.22 billion, operating 111 branches across the country [4]. - Since July 8, *ST Tianmao's stock has dropped over 40%, currently priced at 1.45 per share, with a total market value of 7.1 billion [4]. - Recently, the stock has shown signs of recovery, with a rare two-day increase of over 4% [4].

Group 1 - The core point of the article is that *ST Tianmao has announced a stock suspension due to its controlling shareholder, Xinliyi Group, planning a significant matter related to the company [1] - The stock suspension will take effect from August 7 and is expected to last no more than two trading days [1] - During the suspension, the company will comply with legal disclosure obligations and will announce relevant updates once the matter is confirmed [1] Group 2 - As of the close on August 6, *ST Tianmao's stock price was 1.45 yuan per share, with a total market capitalization of 71.11 billion yuan [1]

Group 1 - The core point of the article is that *ST Tianmao (000627) announced the receipt of a letter from its controlling shareholder, Xinyi Group, regarding the planning of a significant matter, leading to a temporary suspension of its stock trading [2] - The stock of *ST Tianmao will be suspended from trading starting August 7, with an expected suspension period of no more than two trading days [2] - During the suspension, the company will fulfill its information disclosure obligations in accordance with relevant laws and regulations, and will announce the resumption of trading once the matter is confirmed [2] Group 2 - As of the market close on August 6, *ST Tianmao's stock price was reported at 1.45 yuan per share, with a total market capitalization of 7.111 billion yuan [3]